Elite Pharmaceuticals Inc

ELTP

Exchange: OTC
Industry: Pharmaceutical Preparations
SEC CIK: 0001053369

SEC filings (opens in a new tab)

In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Elite Pharmaceuticals Inc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of ELTP: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Q2 2022	Change
Holders	3	2	−1
Shares	622.1K	659.6K	+37.5K (+6.0%)
Value	$39.0K	$29.0K	−$10.0K (−25.6%)

New holders (0)

Institutions that held Elite Pharmaceuticals Inc at the end of Q2 2022 but not at the end of Q1 2022.

None.

Sold out (1)

Institutions that held Elite Pharmaceuticals Inc at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of ELTP in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
IFP Advisors, Inc	200,807	$21.0K